Poolbeg Pharma Plc: Results for the year ended 31 December 2022
Significant milestones reached, well capitalised and positioned for future growth
London, UK 30 March 2023 – Poolbeg Pharma Plc (AIM: POLB, OTCQB: POLBF “Poolbeg” or the “Company”) a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, is pleased to announce its audited results for the year ended 31 December 2022.
